Stock BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Baxter International Inc.

Equities

BAX

US0718131099

Market Closed - Nyse
Other stock markets
 21:00:02 08/05/2024 BST 		5-day change 1st Jan Change
35.75 USD -1.02% Intraday chart for Baxter International Inc. -11.44% -7.53%
05-07 Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31 MT
05-07 Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Baxter International Keeps Quarterly Cash Dividend at $0.29 a Share, Payable July 1 to Shareholders as of May 31
MT
Baxter International Inc. Declares Quarterly Dividend, Payable on July 1, 2024
CI
Baxter International Q1 Adjusted Earnings, Net Sales Gain; Boosts 2024 Adjusted Profit Guidance
MT
(BAX) BAXTER INTERNATIONAL Forecasts Q2 Adjusted EPS Range $0.65 - $0.67
MT
(BAX) BAXTER INTERNATIONAL Sees Fiscal Year 2024 Adjusted EPS Range $2.88 - $2.98
MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Adjusted EPS $0.65 vs. $0.61 Estimate
MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B
MT
Earnings Flash (BAX) BAXTER INTERNATIONAL Reports Q1 Revenue $3.59B
MT
Baxter International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Baxter International Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024
CI
Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S
CI
Pfizer, Baxter, Thermo Fisher, Others FTC Cautioned to Extend Merger Review Period
MT
Baxter International Receives US FDA Clearance for Novum IQ Large Volume Infusion Pump
MT
Baxter International Inc. Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
CI
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data
RE
Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors
MT
Dialysis firms gain as Ozempic kidney trial data disappoints
RE
Ex-dividend day
FA
Spectral Medical Says PMX Distribution and Supply Agreement with Baxter International Extended for 10 Years
MT
Spectral Medical Announcing "Major Milestone" by Reaching Its Interim Enrollment Target of 90 Patients
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. News Baxter International Inc.
  5. Highlights